Literature DB >> 28341428

Renal papillary necrosis in patients with sickle cell disease: How to recognize this 'forgotten' diagnosis.

Michaël M E L Henderickx1, Tim Brits2, Karen De Baets2, Mattias Seghers3, Philip Maes4, Dominique Trouet4, Stefan De Wachter2, Gunter De Win2.   

Abstract

INTRODUCTION: Renal papillary necrosis is not commonly seen in daily practice, but can have severe consequences when it is not diagnosed in time. It is known to be associated with sickle cell hemoglobinopathies; however a wide range of etiologies are possible, and it is therefore not the first diagnosis clinicians consider in patients with sickle cell disease who present with hematuria.
METHODS: A literature search was performed to summarize the current knowledge about renal papillary necrosis associated with sickle cell disease. These findings are illustrated with a case of a 9-year old girl with sickle cell disease who was referred with painless gross hematuria.
RESULTS: Typical radiologic signs for renal papillary necrosis are necrotic cavities that fill with contrast, small collections of contrast peripheral to the calyces in the papillary region (ball-on-tee sign), calcification of the papillary defect, filling defects, hydronephrosis, blunted papillary tip, clefts in the renal medulla filled with contrast, hyperattenuated medullary calcifications, non-enhanced lesions surrounded by rings of excreted contrast, and clubbed calyces. DISCUSSION: This study focuses on the pathophysiology of renal papillary necrosis associated with sickle cell disease, the possible symptoms, as well as the diagnostic steps, with a special interest in particular presentation on old (retrograde pyelography) and new (computed tomography) gold standard in radiologic imaging, and the management for this pathology.
CONCLUSION: This study aims to remind clinicians of this "forgotten" diagnosis and what signs to look for in pediatric patients with sickle cell disease who present with hematuria. In pediatric cases radiation protection is important, therefore knowing what radiologic signs can be found on retrograde pyelography can lead to early identification of this pathology without having to proceed to computed tomography.
Copyright © 2017 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hematuria; Pediatric urology; Radiologic signs; Renal papillary necrosis; Sickle cell disease

Mesh:

Year:  2017        PMID: 28341428     DOI: 10.1016/j.jpurol.2017.01.020

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  6 in total

Review 1.  Imaging review of sickle cell disease for the emergency radiologist.

Authors:  Shenise N Gilyard; Scott L Hamlin; Jamlik-Omari Johnson; Keith D Herr
Journal:  Emerg Radiol       Date:  2020-07-31

Review 2.  The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.

Authors:  Rakhi P Naik; Vimal K Derebail
Journal:  Expert Rev Hematol       Date:  2017-10-30       Impact factor: 2.929

3.  Hematuria and Flank Pain in a Patient with Sickle Cell Trait Who Is Taking NSAIDs.

Authors:  Travis D Homan; Jonathan B Buck; Kana N Miyata
Journal:  Kidney360       Date:  2021-11-25

4.  Renal papillary necrosis with urinary tract obstruction: A case report.

Authors:  Hong-Hong Pan; Yi-Jia Luo; Qing-Guo Zhu; Lie-Fu Ye
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

5.  Sickle cell disease up-regulates vasopressin, aquaporin 2, urea transporter A1, Na-K-Cl cotransporter 2, and epithelial Na channels in the mouse kidney medulla despite compromising urinary concentration ability.

Authors:  Hong Wang; Ryan G Morris; Mark A Knepper; Xiaoming Zhou
Journal:  Physiol Rep       Date:  2019-04

6.  An unusual ultrasound appearance of renal hemosiderosis in acute sickle cell nephropathy.

Authors:  Madison Kocher; Iris Martin; Katherine Twombley; Julie Kanter; Sherron Jackson; Sally Self; Jeanne Hill
Journal:  Radiol Case Rep       Date:  2019-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.